Catechol-O-methyltransferase (COMT) genetic polymorphism in a Turkish population

被引:5
|
作者
Kocabas, NA [1 ]
Karakaya, AE
Cholerton, S
Sardas, S
机构
[1] Gazi Univ, Fac Pharm, Dept Toxicol, TR-06330 Hipodrom Ankara, Turkey
[2] Univ Newcastle Upon Tyne, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
catechol-O-methyltransferase; genotype; genetic polymorphism; Turkish population;
D O I
10.1007/s002040100252
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Catechol-O-methyltransferase (COMT) inactivates neurotransmitters, catechol hormones and drugs such as levodopa and methyldopa. A low activity allele has been demonstrated at codon 108/158 of the soluble and membrane-bound COMT, respectively, whereby a G to A transition results in a valine to methionine substitution. Ethnic and inter-individual differences in red blood cell COMT activity have been observed in the different populations studied so far. Since, no information is available on inter-individual variability of COMT genotype in Turkish population, we genotyped 217 healthy, unrelated Turkish individuals. The allelic frequencies of COMT gene in the Turkish population were found to be the same as has been observed in Caucasians., but different from Orientals.
引用
收藏
页码:407 / 409
页数:3
相关论文
共 50 条
  • [31] CATECHOL-O-METHYLTRANSFERASE (COMT) ACTIVITY IN INBRED STRAINS OF RATS
    WEINSHILBOUM, RM
    [J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 406 - 406
  • [32] COMPLEX ESTROGENIC REGULATION OF CATECHOL-O-METHYLTRANSFERASE (COMT) IN RATS
    Schendzielorz, N.
    Rysa, A.
    Reenila, I.
    Raasmaja, A.
    Mannisto, P. T.
    [J]. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2011, 62 (04): : 483 - 490
  • [33] Pharmacokinetics of levodopa and effect of catechol-O-methyltransferase inhibitors (COMT)
    de la Parte, JFH
    Hernández, MM
    [J]. NEUROLOGIA, 2002, 17 : 57 - 61
  • [34] Catechol-O-methyltransferase (COMT) Val158Met polymorphism and risk of osteoporotic fracture
    Yang Cao
    Dawei Wang
    Bin Liu
    Guijun Yao
    Yutuo Fu
    Zhenggang Bi
    [J]. Molecular Biology Reports, 2012, 39 : 2975 - 2979
  • [35] Catechol-O-methyltransferase (COMT) Val158Met polymorphism and risk of osteoporotic fracture
    Cao, Yang
    Wang, Dawei
    Liu, Bin
    Yao, Guijun
    Fu, Yutuo
    Bi, Zhenggang
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2975 - 2979
  • [36] Catechol-O-methyltransferase (COMT) inhibitors in Parkinson's disease
    Waters, C
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (06) : 692 - 698
  • [37] HUMAN INHERITANCE OF ERYTHROCYTE CATECHOL-O-METHYLTRANSFERASE (COMT) ACTIVITY
    WEINSHILBOUM, RM
    RAYMOND, FA
    [J]. PHARMACOLOGIST, 1976, 18 (02): : 133 - 133
  • [38] Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT)
    Harrison, Scott T.
    Poslusney, Michael S.
    Mulhearn, James J.
    Zhao, Zhijian
    Kett, Nathan R.
    Schubert, Jeffrey W.
    Melamed, Jeffrey Y.
    Allison, Timothy J.
    Patel, Sangita B.
    Sanders, John M.
    Sharma, Sujata
    Smith, Robert F.
    Hall, Dawn L.
    Robinson, Ronald G.
    Sachs, Nancy A.
    Hutson, Pete H.
    Wolkenberg, Scott E.
    Barrow, James C.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (03): : 318 - 323
  • [39] Catechol-O-methyltransferase polymorphism (COMT) in suicide attempters:: A possible gender effect on anger traits
    Baud, Patrick
    Courtet, Philippe
    Perroud, Nader
    JoIlant, Fabrice
    Buresi, Catherine
    Malafosse, Alain
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (08) : 1042 - 1047
  • [40] Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan
    Hamajima N.
    Matsuo K.
    Tajima K.
    Mizutani M.
    Iwata H.
    Iwase T.
    Miura S.
    Oya H.
    Obata Y.
    [J]. International Journal of Clinical Oncology, 2001, 6 (1) : 13 - 18